|
A device
made from a new biomaterial adapted for the treatment of stress
urinary incontinence was introduced at the annual meeting
of the American Urological Association in Orlando, Florida.
The Veritas™
Collagen Matrix has marketing clearance from the U.S. Food
and Drug Administration for use as a sling, an implanted device
for the treatment of stress urinary incontinence, reconstruction
of the pelvic floor and repair of organ prolapse.
In multiple
animal studies, Veritas has been shown to be remodelable;
the implanted tissue acts as a scaffold that the body gradually
"remodels," placing its own cells and new blood
vessels throughout the tissue. Veritas takes on the characteristics,
including strength, of the animal's own tissue. After a month
or more, Veritas may be indistinguishable from the animal's
own tissue. Also, Veritas showed lower levels of inflammation
and adhesions than competitive products.
A clinical
study of Veritas for sling applications is underway at five
medical centers. Early results indicate 100 percent effectiveness,
no infections, no rejections and no erosion of the implanted
tissue.
Source:
Medical Week staff,
week of June 9, 2002
|
HOME PAGE
